Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
ABSTRACT Vaginal HIV microbicides offer great promise in preventing HIV transmission, but failures of phase 3 clinical trials, in which microbicide-treated subjects had an increased risk of HIV transmission, raised concerns about endpoints used to evaluate microbicide safety. A possible explanation...
Guardado en:
Autores principales: | Jacques Ravel, Pawel Gajer, Li Fu, Christine K. Mauck, Sara S. K. Koenig, Joyce Sakamoto, Alison A. Motsinger-Reif, Gustavo F. Doncel, Steven L. Zeichner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7718b81e5254717a9f4623129494649 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.
por: Deirdre E O'Hanlon, et al.
Publicado: (2013) -
Novel Vaginal Microflora Colonization Model Providing New Insight into Microbicide Mechanism of Action
por: Raina N. Fichorova, et al.
Publicado: (2011) -
Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability.
por: Stéphane Verguet, et al.
Publicado: (2010) -
Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS
por: Gupta SK, et al.
Publicado: (2013) -
Daily Vaginal Microbiota Fluctuations Associated with Natural Hormonal Cycle, Contraceptives, Diet, and Exercise
por: Stephanie D. Song, et al.
Publicado: (2020)